vimarsana.com

Latest Breaking News On - Single ascending dose - Page 14 : vimarsana.com

Positive Phase I results for Pipe-307 treatment for MS

Pipe-307 demonstrated linear pharmacokinetic (PK) data consistent with pre-clinical modelling and was generally well tolerated.

AlzeCure presents new clinical data with ACD856 at Alzheimer s conference

AlzeCure presents new clinical data with ACD856 at Alzheimer's conferenceAlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain,.

AlzeCure Presents New Clinical Data with ACD856 at Alzheimer s Conference

AlzeCure Presents New Clinical Data with ACD856 at Alzheimer s Conference
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.